Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.

Atsushi HiraokaTakashi KumadaKazuya KariyamaKoichi TakaguchiEi ItobayashiNoritomo ShimadaKazuto TajiriKunihiko TsujiToru IshikawaHironori OchiMasashi HirookaAkemi TsutsuiHiroshi ShibataToshifumi TadaHidenori ToyodaKazuhiro NousoKouji Joko Yoichi HiasaKojiro Michitakanull null

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2018)

Early therapeutic response to LEN was favorable. This new TKI could have therapeutic potential both in patients with and without past TKI treatments.

Keyphrases

clinical practice
tyrosine kinase
advanced non small cell lung cancer
chronic myeloid leukemia
cross sectional
squamous cell carcinoma